Information  X 
Enter a valid email address

Assura plc (AGR)


Friday 05 November, 2021

Assura plc

Investor Presentation

RNS Number : 4306R
Assura PLC
05 November 2021

5 November 2021

Assura plc

Investor Presentation

Assura plc ("Assura" or "the Company"), the UK's leading primary care property investor and developer, is pleased to announce that Jonathan Murphy (CEO) and Jayne Cottam (CFO) will host a live presentation relating to the Interim Results for the six months ended 30 September 2021 via the Investor Meet Company platform on Friday 12th November 2021 at 3.00pm GMT.

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via the Investor Meet Company dashboard until 9.00am the day before the meeting or at any time during the live presentation.  

Investors can sign up to Investor Meet Company for free and register to follow Assura plc via this link:

Investors who already follow Assura plc on the Investor Meet Company platform will automatically be invited to the event.

- ENDS -


For more information, please contact:

Assura plc

David Purcell, Head of Investor Relations

Tel: 01925 420680

Email: [email protected]


Gordon Simpson
James Thompson

Tel: 0207 251 3801

Email: [email protected]


Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 31 March 2021, Assura's property portfolio was valued at £2,453 million.


Further information is available at


*EPRA is a registered trademark of the European Public Real Estate Association.


Assura plc LEI code: 21380026T19N2Y52XF72


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t